Curcumin protects rat liver from streptozotocin-induced diabetic pathophysiology by counteracting reactive oxygen species and inhibiting the activation of p53 and MAPKs mediated stress response pathways

Ghosh, 2011, The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis, Biomaterials, 32, 4857, 10.1016/j.biomaterials.2011.03.048

Das, 2012, Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review, Food Funct, 2, 1251, 10.1039/c2fo30117b

Maritim, 2003, Diabetes, oxidative stress, and antioxidants: a review, J. Biochem. Mol. Toxicol., 17, 24, 10.1002/jbt.10058

Giacco, 2010, Oxidative stress and diabetic complications, Circulation research, 107, 1058, 10.1161/CIRCRESAHA.110.223545

Das, 2012, Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats, Amino Acids, 43, 1509, 10.1007/s00726-012-1225-y

Lin, 2009, Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress, Lab. Invest., 89, 1397, 10.1038/labinvest.2009.115

Schraufstatter, 1949, Antibacterial action of curcumin and related compounds, Nature, 164, 456, 10.1038/164456a0

Sharma, 1976, Antioxidant activity of curcumin and related compounds, Biochem. Pharmacol., 25, 1811, 10.1016/0006-2952(76)90421-4

Sharma, 2006, Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats, Clin. Exp. Pharmacol. Physiol., 33, 940, 10.1111/j.1440-1681.2006.04468.x

Nishiyama, 2005, Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice, J. Agric. Food Chem., 53, 959, 10.1021/jf0483873

Aggarwal, 2009, Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets, Trends Pharmacol. Sci., 30, 85, 10.1016/j.tips.2008.11.002

Gupta, 2011, Multitargeting by curcumin as revealed by molecular interaction studies, Nat. Prod. Rep., 28, 1937, 10.1039/c1np00051a

Dhillon, 2008, Phase II trial of curcumin in patients with advanced pancreatic cancer, Clin. Cancer Res., 14, 4491, 10.1158/1078-0432.CCR-08-0024

Kim, 2011, Curcumin treatment suppresses IKKbeta kinase activity of salivary cells of patients with head and neck cancer: a pilot study, Clin. Cancer Res., 17, 5953, 10.1158/1078-0432.CCR-11-1272

Holt, 2005, Curcumin therapy in inflammatory bowel disease: a pilot study, Dig. Dis. Sci., 50, 2191, 10.1007/s10620-005-3032-8

Sharma, 2001, Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels, Clin. Cancer Res., 7, 1452

Sharma, 2001, Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer, Clin. Cancer Res., 7, 1894

He, 2011, Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin, Cancer Invest., 29, 208, 10.3109/07357907.2010.550592

Kalpravidh, 2010, Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids, Clin. Biochem., 43, 424, 10.1016/j.clinbiochem.2009.10.057

Heng, 2000, Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters, Br. J. Dermatol., 143, 937, 10.1046/j.1365-2133.2000.03767.x

Shoskes, 2005, Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial, Transplantation, 80, 1556, 10.1097/01.tp.0000183290.64309.21

Gupta, 2013, Therapeutic roles of curcumin: lessons learned from clinical trials, AAPS J., 15, 195, 10.1208/s12248-012-9432-8

Palma, 2014, Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin, Mol. Cell. Biochem., 386, 199, 10.1007/s11010-013-1858-5

Sun, 2013, Effects of curcumin intake on kidney and liver pathological changes in T2DM rats, Wei Sheng Yan Jiu, 42, 6

Abdel Aziz, 2012, Effect of novel water soluble curcumin derivative on experimental type-1 diabetes mellitus (short term study), Diabetol. Metab. Syndr., 4, 30, 10.1186/1758-5996-4-30

Pari, 2010, Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes, Mol. Cell. Biochem., 341, 109, 10.1007/s11010-010-0442-5

Ganda, 1976, Studies on streptozotocin diabetes, Diabetes, 25, 595, 10.2337/diab.25.7.595

Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3

Kornberg, 1955, Lactic dehydrogenase of muscle, 441, 10.1016/0076-6879(55)01072-0

Green, 1982, Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids, Anal. Biochem., 126, 131, 10.1016/0003-2697(82)90118-X

Suresh, 2006, Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus, Prostaglandins Leukot. Essent. Fatty Acids, 74, 199, 10.1016/j.plefa.2005.11.006

Esterbauer, 1990, Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal, Methods Enzymol., 186, 407, 10.1016/0076-6879(90)86134-H

Ellman, 1959, Tissue sulfhydryl groups, Arch. Biochem. Biophys., 82, 70, 10.1016/0003-9861(59)90090-6

Hissin, 1976, A fluorometric method for determination of oxidized and reduced glutathione in tissues, Anal. Biochem., 74, 214, 10.1016/0003-2697(76)90326-2

Benzie, 1999, Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration, Methods Enzymol., 299, 15, 10.1016/S0076-6879(99)99005-5

Manna, 2008, Protection of arsenic-induced testicular oxidative stress by arjunolic acid, Redox Rep., 13, 67, 10.1179/135100008X259169

Bonaventura, 1972, Human erythrocyte catalase: an improved method of isolation and a reevaluation of reported properties, Arch. Biochem. Biophys., 150, 606, 10.1016/0003-9861(72)90080-X

Habig, 1974, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J. Biol. Chem., 249, 7130, 10.1016/S0021-9258(19)42083-8

Smith, 1988, Assay of glutathione reductase in crude tissue homogenates using 5,5′-dithiobis(2-nitrobenzoic acid), Anal. Biochem., 175, 408, 10.1016/0003-2697(88)90564-7

Flohe, 1984, Assays of glutathione peroxidase, Methods Enzymol., 105, 114, 10.1016/S0076-6879(84)05015-1

Hodarnau, 1973, Isolation of highly purified mitochondria from rat pancreas, J. Cell Biol., 59, 222, 10.1083/jcb.59.1.222

Pari, 2007, Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats, Ren Fail, 29, 881, 10.1080/08860220701540326

Bonner-Weir, 1981, Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia, Diabetes, 30, 64, 10.2337/diab.30.1.64

Fernandez-Alvarez, 2004, Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate, Diabetologia, 47, 470, 10.1007/s00125-004-1332-8

Srinivasan, 2007, Animal models in type 2 diabetes research: an overview, Indian J Med Res., 125, 451

Srinivasan, 2005, Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening, Pharmacol Res., 52, 313, 10.1016/j.phrs.2005.05.004

Szkudelski, 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol. Res., 50, 537

1996, Clinical development plan: curcumin, J. Cell. Biochem. Suppl., 26, 72

Perkins, 2002, Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis, Cancer Epidemiol. Biomark. Prev., 11, 535

Anand, 2007, Bioavailability of curcumin: problems and promises, Mol. Pharm., 4, 807, 10.1021/mp700113r

Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med., 64, 353, 10.1055/s-2006-957450

Chainani-Wu, 2003, Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa), J. Altern. Complement. Med., 9, 161, 10.1089/107555303321223035

Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res., 21, 2895

Bisht, 2007, Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy, J. Nanobiotechnol., 5, 3, 10.1186/1477-3155-5-3

Maiti, 2007, Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats, Int. J. Pharm., 330, 155, 10.1016/j.ijpharm.2006.09.025

Tiyaboonchai, 2007, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles, Int. J. Pharm., 337, 299, 10.1016/j.ijpharm.2006.12.043

Kroncke, 1995, Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage, Biol. Chem. Hoppe-Seyler, 376, 179, 10.1515/bchm3.1995.376.3.179

Morgan, 1994, Treatment of cultured pancreatic B-cells with streptozotocin induces cell death by apoptosis, Biosci. Rep., 14, 243, 10.1007/BF01209729

Turk, 1993, Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets, Biochem. Biophys. Res. Commun., 197, 1458, 10.1006/bbrc.1993.2641

Marnett, 1999, Lipid peroxidation-DNA damage by malondialdehyde, Mutat. Res., 424, 83, 10.1016/S0027-5107(99)00010-X

Meister, 1983, Glutathione, Annu. Rev. Biochem., 52, 711, 10.1146/annurev.bi.52.070183.003431

Meister, 1988, Glutathione metabolism and its selective modification, J. Biol. Chem., 263, 17205, 10.1016/S0021-9258(19)77815-6

Nithipongvanitch, 2007, Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment, J. Histochem. Cytochem., 55, 629, 10.1369/jhc.6A7146.2007

Nakamura, 2012, p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation, Circ. Heart Fail., 5, 106, 10.1161/CIRCHEARTFAILURE.111.961565

Jazayeri, 2008, Diabetes increases p53-mediated apoptosis following ischemia, Plast. Reconstr. Surg., 121, 1135, 10.1097/01.prs.0000302499.18738.c2

Hoshino, 2014, Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic beta-cell function in diabetes, Proc. Natl. Acad. Sci. U. S. A., 111, 3116, 10.1073/pnas.1318951111

Deshpande, 2013, Transforming growth factor-beta-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy, Diabetes, 62, 3151, 10.2337/db13-0305

Singh, 2012, Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment, BMC Mol. Biol., 13, 28, 10.1186/1471-2199-13-28

Manna, 2010, Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: prophylactic role of arjunolic acid, Free Radic. Biol. Med., 48, 1465, 10.1016/j.freeradbiomed.2010.02.025

Roux, 2004, ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions, Microbiol. Mol. Biol. Rev., 68, 320, 10.1128/MMBR.68.2.320-344.2004

Khatun, 2013, p53 activation and mitochondria-mediated pathway are involved during hanging death-induced neuronal cell apoptosis in dentate gyrus region of the rat brain, Springerplus, 2, 407, 10.1186/2193-1801-2-407

Das, 2012, Taurine protects rat testes against doxorubicin-induced oxidative stress as well as p53, Fas and caspase 12-mediated apoptosis, Amino Acids, 42, 1839, 10.1007/s00726-011-0904-4

Lai, 2003, Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of PI 3 kinase/Akt pathway, Mol. Cell. Endocrinol., 205, 99, 10.1016/S0303-7207(03)00200-4

Li, 2004, Mitochondrial activation of apoptosis, Cell, 116, S57, 10.1016/S0092-8674(04)00031-5

Li, 1997, Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade, Cell, 91, 479, 10.1016/S0092-8674(00)80434-1

Salvesen, 2002, Caspases: opening the boxes and interpreting the arrows, Cell Death Differ., 9, 3, 10.1038/sj.cdd.4400963

Walters, 2009, A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis, Biochem. J., 424, 335, 10.1042/BJ20090825